当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析 - 资产负债表

派林生物

(000403)

  

流通市值:193.51亿  总市值:206.19亿
流通股本:6.88亿   总股本:7.33亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金782,081,504.22889,546,022.34973,510,3011,000,797,127.67
应收票据及应收账款617,988,386.79561,768,985.47564,541,628.61873,482,542.06
其中:应收票据91,969,860.12102,837,865.35103,663,605.3437,605,500.38
应收账款526,018,526.67458,931,120.12460,878,023.27835,877,041.68
应收款项融资2,542,87914,798,775.3717,827,102.0417,598,206.37
预付款项29,998,126.0143,766,654.3473,497,275.4357,567,162.11
其他应收款合计19,029,176.8142,743,068.2769,818,438.649,713,717.14
其中:应收利息1,627,798.016,213,698.6330,549,575.3417,234,506.83
存货957,335,186.62891,048,288.09788,805,196.76623,689,205.55
其他流动资产1,928,633.371,959,962.832,086,873.931,692,527.51
流动资产平衡项目0000
流动资产合计3,072,354,748.783,034,930,803.352,985,750,503.883,046,975,789.6
非流动资产:
长期应收款600,000,000600,000,000600,000,000600,000,000
投资性房地产340,354.07347,474.03354,593.99361,713.95
固定资产918,132,084.71904,573,538.89846,187,219.61873,672,632.87
在建工程546,461,758.26482,771,977.71427,883,249.48385,734,761.75
使用权资产30,677,904.8932,788,248.1434,955,912.437,213,218.5
无形资产215,990,131.39219,747,549.81196,550,565.79192,515,650.61
开发支出68,252,236.2859,418,560.7483,482,640.2980,027,521.01
商誉2,614,611,614.122,614,611,614.122,614,611,614.122,614,611,614.12
长期待摊费用11,798,899.687,691,577.548,628,194.459,673,513.2
递延所得税资产43,417,152.7649,230,314.2146,034,412.4449,092,460.33
其他非流动资产122,572,322.2481,178,94881,391,821.6892,445,589.83
非流动资产平衡项目0000
非流动资产合计5,172,254,458.45,052,359,803.194,940,080,224.254,935,348,676.17
资产平衡项目0000
资产总计8,244,609,207.188,087,290,606.547,925,830,728.137,982,324,465.77
流动负债:
短期借款273,583,221.31284,226,128.75271,297,113.99275,102,084.06
应付票据及应付账款146,860,230.85108,482,686.27115,509,146.31158,369,564.62
应付账款146,860,230.85108,482,686.27115,509,146.31158,369,564.62
预收款项-20,952.3852,380.95-
合同负债9,617,518.433,374,182.713,485,860.825,911,188.08
应付职工薪酬32,093,709.233,590,031.422,630,318.5456,048,178.54
应交税费48,115,987.3330,426,454.4628,110,079.6283,825,019.44
其他应付款合计317,134,887.83395,758,613.46322,076,571.92326,846,235.4
应付股利495,732.458,875,428.86264,072.08264,072.08
一年内到期的非流动负债10,358,628.4518,796,293.8918,277,016.315,776,496.87
其他流动负债6,976,089.085,847,360.926,830,752.9817,430,128.93
流动负债平衡项目0000
流动负债合计844,740,272.45910,522,704.23798,269,241.41959,308,895.94
非流动负债:
长期借款167,391,167.62143,475,235.6299,365,45052,886,000
租赁负债30,842,625.7624,372,053.3427,036,911.3529,594,238.86
长期应付款9,000,0009,000,0009,000,0009,000,000
递延收益37,538,695.8638,932,988.9138,246,630.2340,082,945.32
递延所得税负债25,836,857.5328,284,759.9528,832,296.0530,325,149.53
非流动负债平衡项目0000
非流动负债合计270,609,346.77244,065,037.82202,481,287.63161,888,333.71
负债平衡项目0000
负债合计1,115,349,619.221,154,587,742.051,000,750,529.041,121,197,229.65
所有者权益(或股东权益):
实收资本(或股本)732,645,729732,645,729732,633,819732,386,720
资本公积4,785,913,604.584,786,377,183.184,785,803,471.234,779,006,783.88
减:库存股43,172,950.3757,385,514.6836,215,522.1536,215,522.15
其他综合收益56,531.2261,114.3126,403.5635,543.87
盈余公积111,806,029.75109,609,210.92105,670,841105,670,841
未分配利润1,548,088,718.641,367,227,289.171,343,015,931.891,286,639,844.36
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计7,135,337,662.826,938,535,011.96,930,934,944.536,867,524,210.96
少数股东权益-6,078,074.86-5,832,147.41-5,854,745.44-6,396,974.84
股东权益平衡项目0000
股东权益合计7,129,259,587.966,932,702,864.496,925,080,199.096,861,127,236.12
负债和股东权益合计8,244,609,207.188,087,290,606.547,925,830,728.137,982,324,465.77
公告日期2023-10-312023-08-242023-04-292023-04-29
审计意见(境内)标准无保留意见
TOP↑